Bayer appoints WA Health to lead government affairs for cardiovascular disease

WA Health, the specialist health practice of WA Communications, has been appointed by Bayer to lead the government affairs brief for their blockbuster cardiovascular brand. WA was brought in following a competitive pitch and will focus on supporting market access preparations for their expansion into coronary or peripheral arterial disease (CAD / PAD) as wellRead more

The future is female: how women’s health got technical

The #MeToo and Time’s Up movements have created (and been a direct response to) some of the biggest headlines of 2018. They have created a renewed focus on many of the lingering inequalities women continue to face in the workplace, as members of society (both in the UK and elsewhere) and in the eyes ofRead more

What does Hancock’s ‘tech revolution’ mean for health-tech and AI?

Given his well-publicised love of all things tech and digital, it comes as no surprise that Matt Hancock’s main priority as Health Secretary will be to overhaul technology in the NHS. Steeped in his family’s software company before entering politics, and driver of a much-praised digital government and economic strategies he seems, on paper, theRead more

Making staying healthy childs play: Prioritising physical activity among children

As the new year starts, Victoria Wilkinson looks at children’s health across the school year. This week, school children across the country are returning from the long summer holiday. The holidays are, for many children, a period of fun and adventure, and they will no doubt be returning to school with lots of stories toRead more

Keeping pace with the Fourth Industrial Revolution

The release of the new Westworld and Humans series may have offered some escapism over recent months. But as the march towards the fourth industrial revolution continues apace, science fiction is fast becoming science fact. As we edge closer to the technology of tomorrow, a fierce debate has emerged about whether the UK workforce isRead more

Pharmaceutical pricing: who holds the cards now?

Negotiations between NHS England and Vertex over access to vital CF drugs have reached an impasse. Both sides appear to have dug their heels into the ground, with patients and politicians left frustrated at the prospect of yet more delays. Some are increasingly despondent over the prospect that a deal may never be reached. TheRead more